Growth Metrics

Evolent Health (EVH) Short-term Investments (2016 - 2026)

Evolent Health has reported Short-term Investments over the past 11 years, most recently at $26.1 million for Q4 2025.

  • For Q4 2025, Short-term Investments fell 55.93% year-over-year to $26.1 million; the TTM value through Dec 2025 reached $26.1 million, down 55.93%, while the annual FY2025 figure was $26.1 million, 55.93% down from the prior year.
  • Short-term Investments for Q4 2025 was $26.1 million at Evolent Health, up from $23.7 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $75.7 million in Q4 2021 and troughed at $13.8 million in Q4 2023.
  • A 5-year average of $33.1 million and a median of $24.0 million in 2025 define the central range for Short-term Investments.
  • Biggest five-year swings in Short-term Investments: soared 426.54% in 2021 and later plummeted 80.85% in 2022.
  • Year by year, Short-term Investments stood at $75.7 million in 2021, then plummeted by 80.85% to $14.5 million in 2022, then decreased by 5.0% to $13.8 million in 2023, then soared by 330.67% to $59.3 million in 2024, then crashed by 55.93% to $26.1 million in 2025.
  • Business Quant data shows Short-term Investments for EVH at $26.1 million in Q4 2025, $23.7 million in Q3 2025, and $24.4 million in Q2 2025.